期刊论文详细信息
International Cardiovascular Forum Journal | |
The Management of Co-Morbidities in Patients with Heart Failure – Iron Deficiency | |
Ewa Jankowska1  Stefan D Anker2  Stephan von Haehling2  | |
[1] Cardiology Department, Centre for Heart Diseases, Military Hospital, Wroclaw, Poland.;Innovative Clinical Trials, Dept. of Cardiology & Pneumology, Universitätsmedizin Göttingen, D-37099 Göttingen, Germany 3:02 PM; | |
关键词: Heart Failure; Cardiology; Guidelines; Iron Deficiency; Anaemia; | |
DOI : https://doi.org/10.17987/icfj.v10i0.440 | |
来源: DOAJ |
【 摘 要 】
Co-morbidities have been recognised as playing a crucial role in the progress of the older patient with HF in particular. The 2016 ESC/HFA HF guidelines stress the significance of co-morbidities more than any previous guidelines have. Iron deficiency is a comorbidity, that has received very little attention until the last decade, as evidence has accumulated both for the significance of this co-morbidity and the emergence of safe effective therapies that appear to offer significant benefits to the HF population who suffer this co-morbidity.
【 授权许可】
Unknown